James A. Rogers - Concepedia

Author

James A. Rogers

Also Known As

J A Rogers, J ROGERS, J Rogers, J. A. ROGERS, J. A. Rogers, J. Rogers, J.A. Rogers, James A Rogers, James A. ROGERS, James A. Rogers

168

Publications

3.9K

Citations

H-Index

129

Concepts

All Affiliations

University of Alberta University of Calgary Metrum Research Group (United States)Pfizer (United States)

About

James A. Rogers is an author at University of Alberta specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	24	1.4K
2	Engineering	7	7	218
3	Arts	1	1	13
4	Health Sciences	1	1	16
5	Natural Sciences	1	1	47

James A. Rogers

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement Jean W. Lee, Viswanath Devanarayan, Yu Chen Barrett, Pharmaceutical Research Biomarker (Medicine)Successful Biomarker MeasurementMedicineBiomarker TargetBioanalysis	2006	744
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination Michael B. Keough, James A. Rogers, Ping Zhang, Nature Communications	2016	198
Mechanisms of lysophosphatidylcholine‐induced demyelination: A primary lipid disrupting myelinopathy Jason R. Plemel, Nathan J. Michaels, Nina Weishaupt, Glia	2017	188
Darwinism and Social Darwinism James A. Rogers Journal of the History of Ideas Social DarwinismAnthropologyEvolutionary TheoryEvolutionary DynamicHuman Evolution	1972	123
Biochemically altered myelin triggers autoimmune demyelination Andrew V. Caprariello, James A. Rogers, Megan L. Morgan, Proceedings of the National Academy of Sciences	2018	102
Liposomal Formulations of Synthetic MUC1 Peptides: Effects of Encapsulation versus Surface Display of Peptides on Immune Responses Holly H. Guan, W Budzyński, R. Rao Koganty, Bioconjugate Chemistry	1998	95
Thermodynamics of partitioning of β-blockers in the n-octanol- buffer and liposome systems G. V. Betageri, James A. Rogers International Journal of Pharmaceutics Proteinlipid InteractionN-octanol- BufferBiochemistryLiposome SystemsLipid Movement	1987	93
The Potential of Liposomes in Oral Drug Delivery James A. Rogers, Keith E. Anderson Critical Reviews in Therapeutic Drug Carrier Systems Cell-based Drug DeliveryNanomedicineLipid PreparationEngineeringMedicine	1998	90
Formulation and Evaluation of a Folic Acid Receptor-Targeted Oral Vancomycin Liposomal Dosage Form Keith E. Anderson, Lise Eliot, Bruce R. Stevenson, Pharmaceutical Research	2001	80
Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution test John S. Grundy, Keith E. Anderson, James A. Rogers, Journal of Controlled Release Pharmaceutical ScienceGastrointestinal PharmacologyMedicineDissolution TestingVitro Dissolution Test	1997	69

Page 1